| Literature DB >> 2563001 |
A Palmer1, D Taube, K Welsh, M Bewick, P Gjorstrup, M Thick.
Abstract
10 highly and persistently sensitised patients awaiting renal transplantation underwent extracorporeal immunoadsorption to remove anti-HLA antibodies. 7 patients have since received transplants. Only 1 allograft has been lost because of rejection, and there have been no serious side-effects attributable to treatment. Extracorporeal immunoadsorption may therefore be of considerable value in the management of highly sensitised patients.Entities:
Mesh:
Substances:
Year: 1989 PMID: 2563001 DOI: 10.1016/s0140-6736(89)91672-3
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321